FIELD: biotechnology, medicine. SUBSTANCE: invention relates to preparing monoclonal antibody R6-5-D6 that inhibits interaction of lymphocytes with glycoprotein of cellular adhesion ICAM-1. Antibodies were produced by murine hybridoma and belong to isotype Ig G2a. They can inhibit proliferation of mononuclear cells of human peripheral blood in systems depending on intercellular adhesion. Invention can be used in medicine for treatment of allergy, oncological diseases, in tissue transplantation. EFFECT: enhanced effectiveness of antibody. 4 dwg
Authors
Dates
1997-09-20—Published
1992-05-06—Filed